The European Medicines Agency's scientific opinion on oral fexinidazole for human African trypanosomiasis

PLoS Negl Trop Dis. 2019 Jun 27;13(6):e0007381. doi: 10.1371/journal.pntd.0007381. eCollection 2019 Jun.
No abstract available

MeSH terms

  • Administration, Oral
  • Drug Approval
  • Drug-Related Side Effects and Adverse Reactions
  • Humans
  • Nitroimidazoles / adverse effects
  • Nitroimidazoles / therapeutic use*
  • Treatment Outcome
  • Trypanocidal Agents / adverse effects
  • Trypanocidal Agents / therapeutic use*
  • Trypanosomiasis, African / drug therapy*

Substances

  • Nitroimidazoles
  • Trypanocidal Agents
  • fexinidazole

Grants and funding

The authors received no specific funding for this work.